A decrease in Tks4 or Tks5 in cancer cells leads to reduced cell metastasis, suggesting that inhibition of pseudopodia has an additional antimetastatic effect, leading to further reduction in metastasis efficiency [52]. Here, SH3PXD2A is linked to cancer.